Skip to main content

July 2025

Crack GPAT — Prepare for GPAT Online 

National Institute of Immunology Openings for Life Sciences or Biotechnology

National Institute of Immunology require Biotechnology or Life Science candidate. experience in basic molecular biology, cloning, expression, and purification of recombinant proteins
Applications are invited for JRF at Institute of Nano Science and Technology
Post Graduate degree in Chemistry or Graduate, Post Graduate Degree in Professional Course selected through National Eligibility Tests – CSIR-UGC NET including lectureship Assistant Professorship or GATE. 
Interview for PG in Life Sciences candidates at PGIMER
Post Graduate Degree Life Science, including the integrated PG degree selected through any one of the following exams CSIR/UGC/GATE/ICMR
ANRF-Convergence Research Centres of Excellence for Pharmacy and Life Sciences
Anusandhan National Research Foundation aims to establish convergence research Centres of Excellence to undertake cutting edge, innovative and impactful research at the interface of Science, Technology, Humanities, Social Sciences and Society.
M.Pharm, MSc candidates hiring at Apitoria Pharma - Executive / Senior Executive Post
Responsible for LC-MS, MS method development, method validation and batch analysis. Impurity profiling for identification of unknown impurities in small molecules.
Walk in Drive for D.Pharm, B.Pharm, M.Pharm in Production and Quality at Granules India
Granules India is a vertically integrated, high-growth pharmaceutical company with 38 years of proven performance and increasing performance and increasing presence across the world.
Aculife Healthcare looking for Research Scientist / Executive - M.Pharm Apply
PHARMACY GRADUATE WITH 3 TO 7 YEARS OF EXPERIENCE IN FORMULATION DEVELOPMENT OF STERILE DOSAGE FORMS AS PER GUIDELINES OF US, EU, CANADA, BRAZIL AND ROW MARKET.
Hiring IPR Executive / Senior Executive at Apitoria Pharma - M.Pharm, MSc Apply
Candidate should have experience in the IP evaluation of APIs, Infringement analysis, FTO analysis and summary reports, patent searching, patent drafting, patent filing and patent prosecution.
Glenmark and AbbVie sign USD 700 million drug licensing agreement
AbbVie and IGI Therapeutics SA, a wholly owned subsidiary of New York-based Ichnos Glenmark Innovation, Inc. (IGI), today announced an exclusive licensing agreement for IGIs lead investigational asset, ISB 2001, developed using IGIs proprietary BEAT protein platform, for oncology and autoimmune diseases
Ascentage Pharma Announces Its Novel Bcl-2 Inhibitor Lisaftoclax Approved by China NMPA, Ushering in a New Era for the Treatment of CLL/SLL

Ascentage Pharma a global biopharmaceutical company dedicated to addressing unmet medical needs in cancers, announced that its proprietary novel Bcl-2 selective inhibitor lisaftoclax (APG-2575) has been approved by China’s National Medical Products Administration (NMPA) for the treatment of adult patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) who have previously received at least one systemic therapy including Bruton’s tyrosine kinase (BTK) inhibitors, which makes lisaftoclax the first Bcl-2 inhibitor receiving conditional approval